Sweden · Delayed Price · Currency is SEK Mycronic AB Statistics
Total Valuation
Mycronic AB has a market cap or net worth of SEK 61.67 billion. The enterprise value is 59.35 billion.
| Market Cap | 61.67B |
| Enterprise Value | 59.35B |
Important Dates
The next confirmed earnings date is Tuesday, July 14, 2026.
| Earnings Date | Jul 14, 2026 |
| Ex-Dividend Date | May 7, 2026 |
Share Statistics
Mycronic AB has 195.27 million shares outstanding. The number of shares has decreased by -0.01% in one year.
| Current Share Class | 195.27M |
| Shares Outstanding | 195.27M |
| Shares Change (YoY) | -0.01% |
| Shares Change (QoQ) | +0.10% |
| Owned by Insiders (%) | 0.17% |
| Owned by Institutions (%) | 50.28% |
| Float | 150.39M |
Valuation Ratios
The trailing PE ratio is 37.29 and the forward PE ratio is 37.34. Mycronic AB's PEG ratio is 3.50.
| PE Ratio | 37.29 |
| Forward PE | 37.34 |
| PS Ratio | 7.43 |
| PB Ratio | 7.84 |
| P/TBV Ratio | 15.00 |
| P/FCF Ratio | 37.22 |
| P/OCF Ratio | 34.70 |
| PEG Ratio | 3.50 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 23.44, with an EV/FCF ratio of 35.81.
| EV / Earnings | 35.86 |
| EV / Sales | 7.15 |
| EV / EBITDA | 23.44 |
| EV / EBIT | 26.39 |
| EV / FCF | 35.81 |
Financial Position
The company has a current ratio of 2.35, with a Debt / Equity ratio of 0.05.
| Current Ratio | 2.35 |
| Quick Ratio | 1.59 |
| Debt / Equity | 0.05 |
| Debt / EBITDA | 0.16 |
| Debt / FCF | 0.24 |
| Interest Coverage | 62.47 |
Financial Efficiency
Return on equity (ROE) is 22.17% and return on invested capital (ROIC) is 33.13%.
| Return on Equity (ROE) | 22.17% |
| Return on Assets (ROA) | 12.51% |
| Return on Invested Capital (ROIC) | 33.13% |
| Return on Capital Employed (ROCE) | 25.11% |
| Weighted Average Cost of Capital (WACC) | 8.19% |
| Revenue Per Employee | 3.10M |
| Profits Per Employee | 619,155 |
| Employee Count | 2,673 |
| Asset Turnover | 0.74 |
| Inventory Turnover | 1.79 |
Taxes
In the past 12 months, Mycronic AB has paid 449.00 million in taxes.
| Income Tax | 449.00M |
| Effective Tax Rate | 21.34% |
Stock Price Statistics
The stock price has increased by +78.92% in the last 52 weeks. The beta is 0.72, so Mycronic AB's price volatility has been lower than the market average.
| Beta (5Y) | 0.72 |
| 52-Week Price Change | +78.92% |
| 50-Day Moving Average | 284.35 |
| 200-Day Moving Average | 229.32 |
| Relative Strength Index (RSI) | 64.50 |
| Average Volume (20 Days) | 280,899 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Mycronic AB had revenue of SEK 8.30 billion and earned 1.66 billion in profits. Earnings per share was 8.47.
| Revenue | 8.30B |
| Gross Profit | 4.41B |
| Operating Income | 2.25B |
| Pretax Income | 2.10B |
| Net Income | 1.66B |
| EBITDA | 2.44B |
| EBIT | 2.25B |
| Earnings Per Share (EPS) | 8.47 |
Balance Sheet
The company has 2.72 billion in cash and 401.00 million in debt, with a net cash position of 2.32 billion or 11.89 per share.
| Cash & Cash Equivalents | 2.72B |
| Total Debt | 401.00M |
| Net Cash | 2.32B |
| Net Cash Per Share | 11.89 |
| Equity (Book Value) | 7.87B |
| Book Value Per Share | 40.29 |
| Working Capital | 4.02B |
Cash Flow
In the last 12 months, operating cash flow was 1.78 billion and capital expenditures -120.00 million, giving a free cash flow of 1.66 billion.
| Operating Cash Flow | 1.78B |
| Capital Expenditures | -120.00M |
| Depreciation & Amortization | 190.00M |
| Net Borrowing | -109.00M |
| Free Cash Flow | 1.66B |
| FCF Per Share | 8.49 |
Margins
Gross margin is 53.13%, with operating and profit margins of 27.10% and 19.94%.
| Gross Margin | 53.13% |
| Operating Margin | 27.10% |
| Pretax Margin | 25.35% |
| Profit Margin | 19.94% |
| EBITDA Margin | 29.39% |
| EBIT Margin | 27.10% |
| FCF Margin | 19.97% |
Dividends & Yields
This stock pays an annual dividend of 3.25, which amounts to a dividend yield of 1.06%.
| Dividend Per Share | 3.25 |
| Dividend Yield | 1.06% |
| Dividend Growth (YoY) | -13.33% |
| Years of Dividend Growth | 3 |
| Payout Ratio | 44.35% |
| Buyback Yield | 0.01% |
| Shareholder Yield | 1.08% |
| Earnings Yield | 2.68% |
| FCF Yield | 2.69% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for Mycronic AB is 260.25, which is -18.01% lower than the current price. The consensus rating is "Hold".
| Price Target | 260.25 |
| Price Target Difference | -18.01% |
| Analyst Consensus | Hold |
| Analyst Count | 4 |
| Revenue Growth Forecast (3Y) | 10.07% |
| EPS Growth Forecast (3Y) | 14.20% |
Stock Splits
The last stock split was on June 3, 2025. It was a forward split with a ratio of 2.
| Last Split Date | Jun 3, 2025 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 4 |